| Literature DB >> 33579042 |
Sarah Cristina Gozzi-Silva1,2, Gil Benard1, Ricardo Wesley Alberca1, Tatiana Mina Yendo1, Franciane Mouradian Emidio Teixeira1,2, Luana de Mendonça Oliveira1, Danielle Rosa Beserra1, Anna Julia Pietrobon1,2, Emily Araujo de Oliveira1,2, Anna Cláudia Calvielli Castelo Branco1,2, Milena Mary de Souza Andrade1, Iara Grigoletto Fernandes1, Nátalli Zanete Pereira1, Yasmim Álefe Leuzzi Ramos1, Julia Cataldo Lima1, Bruna Provenci3, Sandrigo Mangini3, Alberto José da Silva Duarte1, Maria Notomi Sato1,2.
Abstract
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 has infected over 90 million people worldwide, therefore it is considered a pandemic. SARS-CoV-2 infection can lead to severe pneumonia, acute respiratory distress syndrome (ARDS), septic shock, and/or organ failure. Individuals receiving a heart transplantation (HT) may be at higher risk of adverse outcomes attributable to COVID-19 due to immunosuppressives, as well as concomitant infections that may also influence the prognoses. Herein, we describe the first report of two cases of HT recipients with concomitant infections by SARS-CoV-2, Trypanosoma cruzi, and cytomegalovirus (CMV) dissemination, from the first day of hospitalization due to COVID-19 in the intensive care unit (ICU) until the death of the patients.Entities:
Keywords: CMV; COVID-19; Chagas disease; SARS-CoV-2; heart transplant; infection; severity
Year: 2021 PMID： 33579042 PMCID： PMC7985779 DOI： 10.3390/tropicalmed6010022
Source DB: PubMed Journal: Trop Med Infect Dis ISSN： 2414-6366